Literature DB >> 15645170

Pulmonary pseudallescheriasis in a patient with healed tuberculosis.

Gulnaz Bashir1, Saman Shakeel, Tehmeena Wani, Dalip K Kakru.   

Abstract

Pulmonary pseudallescheriasis in an immunocompetent patient without a pre-existing cavity or cyst is a rare phenomenon. We report a case of invasive pulmonary pseudallescheriasis in a lobectomised patient treated for tuberculosis. Filamentous fungi with pyriform conidia were seen in the bronchoalveolar lavage fluid . The fungus was identified as Pseudallescheria boydii on culture.

Entities:  

Mesh：

Year:  2004        PMID： 15645170     DOI： 10.1007/s11046-004-2224-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  9 in total

1.  Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.

Authors:  P Muñoz; M Marín; P Tornero; P Martín Rabadán; M Rodríguez-Creixéms; E Bouza
Journal:  Clin Infect Dis       Date:  2000-12       Impact factor: 9.079

2.  Pulmonary tuberculosis associated with invasive pseudallescheriasis.

Authors:  J Tekavec; E Mlinarić-Missoni; V Babic-Vazic
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

3.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Disseminated Pseudallescheria boydii infection in a nonimmunocompromised host.

Authors:  A Khurshid; V T Barnett; M Sekosan; A S Ginzburg; E Onal
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

5.  Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

Authors:  N Jabado; J L Casanova; E Haddad; F Dulieu; J C Fournet; B Dupont; A Fischer; C Hennequin; S Blanche
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

6.  Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.

Authors:  C Girmenia; G Luzi; M Monaco; P Martino
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  In vitro activities of four novel triazoles against Scedosporium spp.

Authors:  A J Carrillo; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 8.  Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.

Authors:  M A Nesky; E C McDougal; J E Peacock
Journal:  Clin Infect Dis       Date:  2000-09-27       Impact factor: 9.079

Review 9.  Clinical significance of Pseudallescheria boydii: a review of 10 years' experience.

Authors:  L B Travis; G D Roberts; W R Wilson
Journal:  Mayo Clin Proc       Date:  1985-08       Impact factor: 7.616
  9 in total
  2 in total

Review 1.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Scedosporium spp lung infection in immunocompetent patients: A systematic review and MOOSE-compliant meta-analysis.

Authors:  Wei Liu; Rui-Zhi Feng; Hong-Li Jiang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.